Trump Blowup With Dem Leadership Could Jeopardize Rx Pricing Deal

By Rachel Cohrs / May 22, 2019 at 2:09 PM
President Donald Trump said Wednesday (May 22) that legislative negotiations on drug pricing are on hold until Democrats stop investigations into his potential role in his campaign’s ties to Russia and into other actions he has taken while in office. The pronouncement came after he cut short a meeting on infrastructure policy with House Speaker Nancy Pelosi (D-CA) and Senate Minority Leader Chuck Schumer (D-NY). The fallout from the failed meeting jeopardizes a drug-pricing deal that the White House has...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.